Nova Patents
LU92005I2

Anti-tnf antibodies / tnf receptor and methotrexate in the treatment of autoimmune disease

Abstract

Use of a tumour necrosis factor (TNF) antagonist for the preparation of a medicament for treatment of a TNF-mediated disease, wherein the TNF antagonist is to be administered as adjunctive therapy to methotrexate.

Term

5.7 yearsto projected expiry

Projected expiry 23 May 2032, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

64 members in 13 offices

This recordMember, by publication datePriority claim3 more offices are in the list below

Priority claims6

Priority claims
DocumentOfficeKindDate
69077596United States of AmericaA
69077596United States of AmericaA
97933799European Patent Office (EPO)A
97933799European Patent Office (EPO)A
EP19970933799–––
US19960690775–––

Members64

Family members, oldest first
DocumentOfficeKind
CA2146647A1CanadaA1
WO9408619A1World Intellectual Property Organization (WIPO)A1
AU5152293AAustraliaA
WO9509652A1World Intellectual Property Organization (WIPO)A1
AU6149594AAustraliaA
EP0663836A1European Patent Office (EPO)A1
JPH08505365AJapanA
EP0765171A1European Patent Office (EPO)A1
EP0663836B1European Patent Office (EPO)B1
AT155043TAustriaT
DE69312077D1GermanyD1
DE69312077T2GermanyT2
JPH09510952AJapanA
CA2261630A1CanadaA1
CA2791778A1CanadaA1
WO9805357A1World Intellectual Property Organization (WIPO)A1
AU3703597AAustraliaA
US5741488AUnited States of AmericaA
EP0914157A1European Patent Office (EPO)A1
HK1020011A1Hong Kong, ChinaA1
AU719015B2AustraliaB2
US6270766B1United States of AmericaB1
US2002010180A1United States of AmericaA1
US2002068057A1United States of AmericaA1
US2002136723A1United States of AmericaA1
US6770279B1United States of AmericaB1
US2004228863A1United States of AmericaA1
JP3616091B2JapanB2
EP0914157B1European Patent Office (EPO)B1
AT305798TAustriaT
EP1593393A2European Patent Office (EPO)A2
DK0914157T3DenmarkT3
DE69734317D1GermanyD1
ES2247635T3SpainT3
US2006099212A1United States of AmericaA1
DE69734317T2GermanyT2
EP1593393A3European Patent Office (EPO)A3
EP1941904A2European Patent Office (EPO)A2
CA2146647CCanadaC
US2009175859A1United States of AmericaA1
EP1941904A3European Patent Office (EPO)A3
US7838489B2United States of AmericaB2
US7846442B2United States of AmericaB2
US2011014188A1United States of AmericaA1
US2011123543A1United States of AmericaA1
EP1593393B1European Patent Office (EPO)B1
AT535255TAustriaT
PT1593393EPortugalE
DK1593393T3DenmarkT3
ES2378446T3SpainT3
EP1941904B1European Patent Office (EPO)B1
US2012141474A1United States of AmericaA1
US2012141475A1United States of AmericaA1
DK1941904T3DenmarkT3
LU92004I2LuxembourgI2
LU92005I2This recordLuxembourgI2
PT1941904EPortugalE
ES2388244T3SpainT3
US8298537B2United States of AmericaB2
CA2261630CCanadaC
LU92098I2LuxembourgI2
LU92099I2LuxembourgI2
US8383120B2United States of AmericaB2
US2013064816A1United States of AmericaA1